Home » FDA WARNS J&J UNIT ON BLOOD-GLUCOSE TESTS
FDA WARNS J&J UNIT ON BLOOD-GLUCOSE TESTS
The Food and Drug Administration warned a unit of Johnson & Johnson for failing to properly investigate and report problems with blood-glucose tests used by people with diabetes. The warning letter, sent to Milpitas, Calif.-based LifeScan Inc., was posted Tuesday to the FDA's Web site.
Minneapolis Star Tribune (http://www.startribune.com/stories/535/5793602.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May